(5-Fluoropyridin-3-yl)boronic acid → 2-Chloro-N-(4-(chlorodifluoromethoxy)phenyl)-5'-fluoro-[3,3'-bipyridine]-5-carboxamide
Reaktionsgleichung
[Cl:1][C:2]1[C:21](I)=[CH:20][C:5]([C:6]([NH:8][C:9]2[CH:14]=[CH:13][C:12]([O:15][C:16]([Cl:19])([F:18])[F:17])=[CH:11][CH:10]=2)=[O:7])=[CH:4][N:3]=1.[F:23][C:24]1[CH:25]=[N:26][CH:27]=[C:28](B(O)O)[CH:29]=1>>[Cl:1][C:2]1[C:21]([C:28]2[CH:27]=[N:26][CH:25]=[C:24]([F:23])[CH:29]=2)=[CH:20][C:5]([C:6]([NH:8][C:9]2[CH:14]=[CH:13][C:12]([O:15][C:16]([Cl:19])([F:18])[F:17])=[CH:11][CH:10]=2)=[O:7])=[CH:4][N:3]=1Komponenten
3
Versuchsvorschrift
The title compound was prepared in an analogous fashion to that described in Stage 247.1 using 6-chloro-N-(4-(chlorodifluoromethoxy)phenyl)-5-iodonicotinamide (Stage 247.2) and 3-Fluoropyridine-5-boronic acid pinacolester (80° C. instead of 90° C.) to afford a white solid. UPLC-MS (Condition 3) tR=1.17 min, m/z=428.0/429.9 [M+H]+.
Aufarbeitung
- custom80° C.
- custominstead of 90° C.